Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H8O4 |
Molecular Weight | 144.1253 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)\C=C\C(=O)OC
InChI
InChIKey=LDCRTTXIJACKKU-ONEGZZNKSA-N
InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+
Molecular Formula | C6H8O4 |
Molecular Weight | 144.1253 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:08:48 UTC 2023
by
admin
on
Fri Dec 15 16:08:48 UTC 2023
|
Record UNII |
FO2303MNI2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29708
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
||
|
WHO-ATC |
N07XX09
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
||
|
NCI_THESAURUS |
C798
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/18/1990
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
406713
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
||
|
WHO-ATC |
L04AX07
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
607917
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
||
|
WHO-VATC |
QN07XX09
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
TECFIDERA (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C63670
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
7045
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
25942
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
1373478
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
C056020
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
QQ-86
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
7725
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
637568
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
m11738
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | Merck Index | ||
|
76004
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
DB08908
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
DTXSID4060787
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
100000079228
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
210-849-0
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
SUB13608MIG
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
4757
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
CHEMBL2107333
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
DIMETHYL FUMARATE
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
Dimethyl fumarate
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
FO2303MNI2
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY | |||
|
624-49-7
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
FO2303MNI2
Created by
admin on Fri Dec 15 16:08:48 UTC 2023 , Edited by admin on Fri Dec 15 16:08:48 UTC 2023
|
PRIMARY | |||
|
167432
Created by
admin on Fri Dec 15 16:08:49 UTC 2023 , Edited by admin on Fri Dec 15 16:08:49 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of total dose excreted; Combined amount with "citric acid"
IN-VIVO
PLASMA
|
||
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of total dose excreted (into Expired Air; 39.7% to 58.6%)
IN-VIVO
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of dose; Amount combined with other cysteine conjugates
IN-VIVO
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of dose
IN-VIVO
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of dose; Amount combined with "Fumaric Acid"
IN-VIVO
PLASMA
|
||
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of dose; Amount combined with other N-acetylcysteine conjugates
IN-VIVO
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of dose; Amount combined with other cysteine conjugates
IN-VIVO
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of dose; Amount combined with other N-acetylcysteine conjugates
IN-VIVO
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Dimethyl fumarate is highly reactive: when administered orally, it does not survive long enough to be absorbed into blood without being attacked by GSH (detoxifying agent). However, part of it is hydrolyzed by esterases to produce monomethylfumarate, which is more resistant
|